SeekingAlpha · Aug 8, 2026
Sandoz Group AG 2026 Q2 - Results - Earnings Call Presentation
2026-08-08. The following slide deck was published by Sandoz Group AG in conjunction with their 2026 Q2 earnings call.
OTC · SDZNY
Sandoz Group AG
Healthcare · Drug Manufacturers - Specialty & Generic
$92.63
Up+$2.81 (+3.13%)
Updated Aug 17, 2026, 5:05 PM
SID Score
5.0/10
Composite research score
Smart Money
46/100
Neutral
- Market cap
- 32.05B
- P/E ratio
- 140.61
- Dividend yield
- 0.78%
- 52-week range
- — – —
- Volume
- 402
- Avg. volume
- 23.64K
Price performance
SDZNY price history
1M range · 0 trading sessions · Daily adjusted prices
SDZNY does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
Latest SDZNY news
The latest Smart Investors Daily articles mentioning SDZNY.
Stock researchCompany · Overview
SDZNY research
Overview
Company profile and research snapshot.
Company profile
SANDOZ GROUP AG S/ADR
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- Buy
- Average target
- $66.64
- Implied upside
- —
- Analysts
- 18
| Date | Firm | Rating | Target |
|---|---|---|---|
| Jul 13, 2026 | ROTHSCHILD & CO REDBURN | Buy | — |
| Jul 2, 2026 | JEFFERIES | Buy | — |
| Jun 7, 2026 | BAADER EUROPE / ALPHAVALUE | Buy | — |
| Apr 30, 2026 | BERENBERG | Hold | — |
| Jan 26, 2026 | ROTHSCHILD & CO REDBURN | Buy | — |
News briefing
No generated briefing is available yet.
SeekingAlpha · Aug 5, 2026
Sandoz Group AG (SDZNY) Q2 2026 Earnings Call Transcript
Sandoz Group AG (SDZNY) Q2 2026 Earnings Call August 5, 2026 3:30 AM EDTCompany ParticipantsCraig Marks - Head of Investor RelationsRichard Saynor - Chief...
SeekingAlpha · Jul 24, 2026
Regeneron: I'm Not Concerned About The Declining ROIC And Operating Margins
Regeneron Pharmaceuticals, Inc. buy case: Dupixent & Libtayo fuel growth despite volatility & Eylea biosimilar risks; margins to recover. Click for an REGN update.
Yahoo · Jun 22, 2026
Sandoz to Host Capital Markets Day: Maximising Sandoz Value in Its Golden Decade for Biosimilars
BASEL, SWITZERLAND - June 22, 2026 (NEWMEDIAWIRE) - Sandoz (SIX:SDZ / OTCQX:SDZNY), the global leader in affordable medicines, will host its 2026 capital markets day for investors and analysts: Tuesday, 8 September 13:30-17:00 UK time London S...
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
